Loading…
Lobbying Spend
—
Filings
58
Firms Hired
1
Active Period
2004–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Grassroots Rural and Small Community Water Systems Assistance Act of 2011
2011 · first_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1427
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · fourth_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · fourth_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (H.R. 1427; H.R. 1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2010 · second_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); implementation of health care reform
Client expense: — · Firm income: $30,000
Matched citations: HR1548
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590; HR 4872
Client expense: — · Firm income: $30,000
Matched citations: HR 3590
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
2010 · first_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590; HR 4872
Client expense: — · Firm income: $30,000
Matched citations: HR 4872
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590; HR 4872
Client expense: — · Firm income: $30,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2010 · first_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590; HR 4872
Client expense: — · Firm income: $30,000
Matched citations: HR1548
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590
Client expense: — · Firm income: $50,000
Matched citations: HR 3590
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · fourth_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590
Client expense: — · Firm income: $50,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2009 · fourth_quarter · Firm: BGR GOVERNMENT AFFAIRS
Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3590
Client expense: — · Firm income: $50,000
Matched citations: HR1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
4Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200; S 1679; Senate health reform package
Client expense: — · Firm income: $50,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2009 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
4Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200; S 1679; Senate health reform package
Client expense: — · Firm income: $50,000
Matched citations: HR1548
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
4Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200; S 1679; Senate health reform package
Client expense: — · Firm income: $50,000
Matched citations: HR 3200
Affordable Health Choices Act
2009 · third_quarter · Firm: BGR GOVERNMENT AFFAIRS
4Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200; S 1679; Senate health reform package
Client expense: — · Firm income: $50,000
Matched citations: S 1679
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: BGR GOVERNMENT AFFAIRS
Dual-eligible Medicare program participants; Patient safety legislation; Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200.
Client expense: — · Firm income: $50,000
Matched citations: HR 1427
Pathway for Biosimilars Act
2009 · second_quarter · Firm: BGR GOVERNMENT AFFAIRS
Dual-eligible Medicare program participants; Patient safety legislation; Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200.
Client expense: — · Firm income: $50,000
Matched citations: HR1548
America's Affordable Health Choices Act of 2009
2009 · second_quarter · Firm: BGR GOVERNMENT AFFAIRS
Dual-eligible Medicare program participants; Patient safety legislation; Patent reform Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics (HR 1427, HR1548); HR 3200.
Client expense: — · Firm income: $50,000
Matched citations: HR 3200
Medicare, Medicaid, and SCHIP Extension Act of 2007
2007 · year_end · Firm: BGR GOVERNMENT AFFAIRS
Dual-eligible Medicare program participants; Prescription mental health medication; Patient safety legislation; Patent reform Medicare Part-D non-interference legislation; FDARA, PDUFA S.2499 (Medicare, Medicaid, and SCHIP Extension Act of 2007) H.R. 3162 (Children's Health and Medicare Protection Act of 2007)
Client expense: — · Firm income: $60,000
Matched citations: S.2499
Source: Senate LDA